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Abstract
Bordetella pertussis strains with the pertussis toxin promoter
allele ptxP3 have expanded and replaced resident ptxP1 strains in
several European countries. We developed an allele-speciﬁc
real-time PCR method to identify strains with the allele ptxP3,
and investigated the emergence of ptxP3 strains by genotyping
Finnish clinical isolates (n = 524) from 1953 to 2010. The ﬁrst
ptxP3 strain was detected in 1994, and has become predominant
since 2003. Our results demonstrate that the allele-speciﬁc real-
time PCR is a suitable method for rapid detection of ptxP3
strains, and show the emergence and establishment of ptxP3
strains in Finland.
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Despite a long history of vaccination with high coverage,
resurgence of pertussis has been observed in the USA, Eur-
ope, Asia, South America, and Australia. Moreover, changes
in the virulence factors of Bordetella pertussis, the causative
agent of pertussis, have been reported in these regions.
Recently, the emergence of strains with a novel allele (ptxP3)
for the B. pertussis toxin promoter was described [1]. The
ptxP3 strains were associated with pertussis resurgence in
The Netherlands and Australia, and produced more pertussis
toxin (Ptx) than ptxP1 strains, which were dominant earlier
in Europe [1–4].
In Finland, the whole cell pertussis vaccine was introduced
in 1952. Acellular pertussis vaccines replaced the whole cell
ones in the Finnish vaccination programme in 2005. The vac-
cination coverage for four doses has been >90% since the
1970s [5]. However, the disease still remains endemic in this
country. In 1999 and 2003–2004, there were two nationwide
epidemics of pertussis, with incidence rates of 17.8 and
24.3–31.3 per 100 000, respectively (Fig. 1) (Infectious Dis-
eases Register, National Institute for Health and Welfare,
Helsinki, Finland). Since 1995, only laboratory-conﬁrmed
cases based on culture, PCR or ELISA serology have been
reported in Finland. During the period 1995–2010, up to 9%
of reported cases were culture-positive.
The purposes of this study were to develop an allele-
speciﬁc real-time PCR for the detection of ptxP3 strains and,
with the rapid method, to assess whether the ptxP3 strains
have emerged in Finland, where vaccination against pertussis
has been used for 60 years.
The isolates tested were from the B. pertussis strain col-
lection of the Pertussis Reference Laboratory of the National
Institute for Health and Welfare, Turku, Finland. The total
number of isolates received was 695 from 1991 to 2010.
From these, 495 (median number of tested isolates/year, 15;
range, 4–142) were randomly selected and typed for ptxP3.
In addition, 29 isolates recovered from 1953 to 1982 were
included.
We developed an allele-speciﬁc real-time PCR for geno-
typing of ptxP3 strains. The template used in the real-time
PCR was a bacterial suspension heated at 95C for 30 min.
The sequences of primers were 5¢-TTCGGCGCAAAGT
CGCGCGAGA-3¢ (forward) and 5¢-GCGTTTTGATGGTG
CCTATT-3¢ (reverse). The forward primer was designed to
speciﬁcally bind ptxP3. To ensure no ampliﬁcation from other
ptxP alleles, a mismatch was added to the second last nucleo-
tide (G) at the 3¢-end of the forward primer. The reaction
volume was 20 lL. The real-time PCR was run on a Light
Cycler I machine (Roche Diagnostics, Mannheim, Germany).
The LightCycler programme for ampliﬁcation was as follows:
denaturation for 600 s at 94C, followed by 30 cycles of 5 s
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at 95C, 5 s at 63C, and 10 s at 72C. The programme for
melting curve analysis was as follows: 0 s at 65C, 30 s at
55C, and 0 s at 94C. Cooling was performed at 40C for
30 s. LightCycler FastStart DNA Master SYBR Green I
(Roche Diagnostics, Penzberg, Germany) was used. Both
positive (ptxP3) and negative (ptxP1) controls were included
in each run. Speciﬁc ampliﬁcation was only observed for
ptxP3 with a speciﬁc melting temperature of c. 84C (mean,
83.75C, standard deviation, 0.54C). Intra-assay variation
was calculated when a positive control was tested in 10 dif-
ferent runs. The real-time PCR results were identical to
those obtained by sequencing when 50 Finnish strains ran-
domly selected from 1992 to 2004 were tested by both
methods. Only ptxP1 and ptxP3 strains were identiﬁed among
the 50 strains tested by sequencing.
When all B. pertussis isolates from 1953 to 1982 were
tested, ptxP3 was not detected. The prevalence of the ptxP1
and ptxP3 strains isolated between 1991 and 2010 is shown
in Fig. 2. In Finland, the ptxP3 strain was ﬁrst detected in
1994, and has become predominant since 2003. An increase
in the frequency of ptxP3 strains was found to coincide with
nationwide pertussis epidemics in 1999 and 2003–2004
(Fig. 1). Since 2007, almost all circulating strains have been
ptxP3.
The allele-speciﬁc real-time PCR proved to be reliable and
accurate, as shown by the correct identiﬁcation of ptxP3
alleles. The advantage of this approach over sequencing is
that the result can be obtained within an hour. Its disadvan-
tage is that novel genotypes can be missed, as well as minor
ptxP alleles other than ptxP1 or ptxP3. The minor alleles are
not a major issue, as they were reported previously at low
frequencies of 9% and 1%, in 1935–1990 and 1991–2004,
respectively, when 1248 isolates collected from Europe, the
Americas, Asia and Africa were analysed [1].
Our results show that ptxP3 strains have become the pre-
dominant type in Finland, and that they have almost totally
replaced ptxP1 strains. Although ptxP3 strains were reported
to be associated with pertussis resurgence in The Nether-
lands and Australia [1,4], in Finland ptxP3 strains cannot be
linked directly to pertussis resurgence. The ﬁnding in this
present study is in line with those observed in Sweden and
Denmark, where the emergence of ptxP3 strains has not
been found to be associated with the increased incidence of
pertussis [2,6].
The allele-speciﬁc real-time PCR method has been proven
to be speciﬁc and rapid for the identiﬁcation of ptxP3 strains,
and can be used to screen large numbers of B. pertussis
isolates.
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